Removing Race From Hyperbilirubinemia Guidelines Is Not Enough
Ostfeld-Johns S, Aragona E, Hart L. Removing Race From Hyperbilirubinemia Guidelines Is Not Enough. JAMA Pediatrics 2022, 176: 1163-1164. PMID: 36251301, DOI: 10.1001/jamapediatrics.2022.3865.Commentaries, Editorials and LettersUsing Quality Improvement Science to Promote Reliable Communication During Family-Centered Rounds.
Glick A, Foster L, Goonan M, Hart L, Alam S, Rosenberg R. Using Quality Improvement Science to Promote Reliable Communication During Family-Centered Rounds. Pediatrics 2022, 149 PMID: 35362064, PMCID: PMC9647567, DOI: 10.1542/peds.2021-050197.Peer-Reviewed Original ResearchConceptsFamily-centered roundsHospital-acquired conditionsRisk factorsDischarge planningPediatric hospital medicine servicePediatric acute care unitHospital medicine serviceAcute care unitsStudy-Act cyclesAcademic medical centerQuality improvement scienceReminder e-mailsRoutine providerClinical outcomesCare unitMedical CenterMedicine servicePhysician educationCenterline shiftPrevention strategiesMultiple interventionsCare deliveryNote templatePhysician engagementStatistical process control chartsRacial and Ethnic Health Disparities Related to COVID-19
Lopez L, Hart LH, Katz MH. Racial and Ethnic Health Disparities Related to COVID-19. JAMA 2021, 325: 719-720. PMID: 33480972, DOI: 10.1001/jama.2020.26443.Peer-Reviewed Original ResearchRace and the 2022 American Academy of Pediatrics Hyperbilirubinemia Guideline—Reply
Ostfeld-Johns S, Aragona E, Hart L. Race and the 2022 American Academy of Pediatrics Hyperbilirubinemia Guideline—Reply. JAMA Pediatrics 2023, 177: 437-437. PMID: 36780144, DOI: 10.1001/jamapediatrics.2022.5910.Commentaries, Editorials and LettersA Comparison of Two Statewide Datasets to Understand Population Prevalence of Substance Use in Pregnancy: Findings and Considerations for Policy & Research
Sieger M, Morin J, Budris L, Sienna M, Ostfeld-Johns S, Hart L, Morosky C. A Comparison of Two Statewide Datasets to Understand Population Prevalence of Substance Use in Pregnancy: Findings and Considerations for Policy & Research. Maternal And Child Health Journal 2024, 28: 1121-1131. PMID: 38539033, PMCID: PMC11060901, DOI: 10.1007/s10995-024-03914-6.Peer-Reviewed Original ResearchConceptsSubstance use disordersSubstance useBlack mothersPregnancy-related deathsFederal Child Abuse PreventionMental health conditionsPublic health aimSelf-reported drug useMaternal self-reportDrug usePrevalence of substance useChild protective services involvementProtective services involvementMothers self-reportedChild abuse preventionSelf-reported dataStatistically similar ratesPrenatal substance exposureSelf-report ratingsHealth aimRate of whitesHispanic mothersHealth conditionsHospital personnelSelf-report